-
1دورية أكاديمية
المؤلفون: Jolien Van den Bossche, Maxime De Laere, Koen Deschepper, Paul Germonpré, Yvan Valcke, Jan Lamont, Barbara Stein, Kirsten Van Camp, Charlotte Germonpré, Griet Nijs, Ella Roelant, Sébastien Anguille, Eva Lion, Zwi Berneman
المصدر: PLoS ONE, Vol 19, Iss 7, p e0307204 (2024)
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1932-6203
-
2دورية أكاديمية
المؤلفون: Paul Germonpré, Tim Van den Wyngaert
المصدر: PLoS ONE, Vol 14, Iss 4, p e0215135 (2019)
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1932-6203
-
3دورية أكاديمية
المؤلفون: Laure Sorber, Karen Zwaenepoel, Koen De Winne, Kaat Van Casteren, Elien Augustus, Julie Jacobs, Xiang Hua Zhang, Daniëlla Galdermans, Els De Droogh, Anneke Lefebure, Ann-Marie Morel, Erika Saenen, Frédérique Bustin, Ingel Demedts, Ulrike Himpe, Thierry Pieters, Paul Germonpré, Sofie Derijcke, Koen Deschepper, Jan P. Van Meerbeeck, Christian Rolfo, Patrick Pauwels
المصدر: Cancers, Vol 10, Iss 9, p 290 (2018)
مصطلحات موضوعية: liquid biopsy, non-small cell lung cancer (NSCLC), EGFR, ctDNA, ddPCR, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4
المؤلفون: Luc Van Zandweghe, Daniella Galdermans, K Pat, Isabelle Fabry, Ingel K. Demedts, Isabelle Declercq, Rika Van Herreweghe, Michiel Thomeer, Kurt G. Tournoy, Patrick Alexander, Sofie De Craene, Valerie Van Damme, Heidi Marien, Luc Vanmaele, Nele De Brucker, Paul Germonpré, Piet Vercauter, Rob Schildermans, Sofie Derijcke, Rebecca De Pauw, Elke Govaerts, Karl Govaert
المصدر: Lung Cancer. 115:49-55
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Programmed Cell Death 1 Receptor, Population, Antineoplastic Agents, Hospitals, General, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Case mix index, Belgium, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Neoplasm Metastasis, Lung cancer, education, Adverse effect, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, education.field_of_study, business.industry, Pneumonia, Middle Aged, Colitis, medicine.disease, Survival Analysis, Confidence interval, Surgery, Nivolumab, 030104 developmental biology, Docetaxel, 030220 oncology & carcinogenesis, Female, Immunotherapy, Neoplasm Recurrence, Local, business, medicine.drug
-
5
المؤلفون: Yves Mentens, Jose Ferri, Godefridus J. Peters, Elisa Giovannetti, Nele Van Der Steen, Paul Germonpré, M. Ramael, Patrick Pauwels, Leticia G. Leon, David R. Gandara, Christian Rolfo
المساهمون: CCA - Cancer biology and immunology, Medical oncology laboratory, Medical oncology, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism
المصدر: Van Der Steen, N, Mentens, Y, Ramael, M, Leon, L G, Germonpré, P, Ferri, J, Gandara, D R, Giovannetti, E, Peters, G J, Pauwels, P & Rolfo, C 2018, ' Double Trouble : A Case Series on Concomitant Genetic Aberrations in NSCLC ', Clinical Lung Cancer, vol. 19, no. 1, pp. 35-41 . https://doi.org/10.1016/j.cllc.2017.06.010
Clinical Lung Cancer, 19(1), 35-41. Elsevier
Clinical lung cancerمصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Viral Oncogene, medicine.disease_cause, Targeted therapy, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Exon, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, Genetic Testing, Molecular Targeted Therapy, Epidermal growth factor receptor, Neoplasm Metastasis, Lung cancer, Genetic testing, biology, medicine.diagnostic_test, business.industry, Middle Aged, Proto-Oncogene Proteins c-met, medicine.disease, ErbB Receptors, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Cancer research, biology.protein, Female, Human medicine, KRAS, business
-
6
المؤلفون: Marcello Tiseo, Godefridus J. Peters, Paul Germonpré, Christian Rolfo, Nele Van Der Steen, Christophe Hermans, Giulia Mazzaschi, Elisa Giovannetti, Karen Zwaenepoel, Daan P. Geerke, Patrick Pauwels, Paul Van Schil, Ken Op de Beeck, Filip Lardon, Rosa A. Luirink
المساهمون: Medical oncology laboratory, AGEM - Re-generation and cancer of the digestive system, CCA - Imaging and biomarkers, AIMMS, Molecular and Computational Toxicology
المصدر: Molecules
Volume 24
Issue 24
Molecules: a journal of synthetic chemistry and natural product chemistry
Molecules, 24(24). Multidisciplinary Digital Publishing Institute
van der Steen, N, Zwaenepoel, K, Mazzaschi, G, A Luirink, R, P Geerke, D, op de Beeck, K, Hermans, C, Tiseo, M, van Schil, P, Lardon, F, Germonpré, P, Rolfo, C, Giovannetti, E, J Peters, G & Pauwels, P 2019, ' The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies ', Molecules, vol. 24, no. 24 . https://doi.org/10.3390/molecules24244443
Molecules, 24(24):4443. Multidisciplinary Digital Publishing Institute (MDPI)
Van Der Steen, N, Zwaenepoel, K, Mazzaschi, G, Luirink, R A, Geerke, D P, De Beeck, K O, Hermans, C, Tiseo, M, Van Schil, P, Lardon, F, Germonpré, P, Rolfo, C, Giovannetti, E, Peters, G J & Pauwels, P 2019, ' The role of c-met as a biomarker and player in innate and acquired resistance in non-small-cell lung cancer : Two new mutations warrant further studies ', Molecules, vol. 24, no. 24, 4443 . https://doi.org/10.3390/molecules24244443مصطلحات موضوعية: Male, Lung Neoplasms, Mutant, Pharmaceutical Science, NSCLC, Analytical Chemistry, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Drug Discovery, Epidermal growth factor receptor, Neoplasm Metastasis, Receptor, 0303 health sciences, biology, Middle Aged, Proto-Oncogene Proteins c-met, 3. Good health, ErbB Receptors, Gene Expression Regulation, Neoplastic, Chemistry, Chemistry (miscellaneous), 030220 oncology & carcinogenesis, Molecular Medicine, Biomarker (medicine), Female, Antibody, Adult, C-Met, EGFR, Article, Deep sequencing, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Biomarkers, Tumor, medicine, Humans, Physical and Theoretical Chemistry, Lung cancer, Biology, Aged, 030304 developmental biology, business.industry, Organic Chemistry, Gene Amplification, medicine.disease, chemistry, Drug Resistance, Neoplasm, Mutation, biology.protein, Cancer research, Tumor Suppressor Protein p53, business, Biomarkers
وصف الملف: application/pdf
-
7
المؤلفون: Oliver Schmalz, K.-P. Fröhling, E. Wiegert, Martin Wolf, Rumo Leistner, Wolfgang Blau, Hans-Georg Kopp, C. Wesseler, Claudia Mauri, W. M. Brückl, Christian Herzmann, Jens Kollmeier, Kerstin Kapp, Veerle Surmont, Parvis Sadjadian, Monika Serke, Michael Thomas, A. Navarro, M. Domine Gomez, Christian Brandts, Burghardt Wittig, Yolanda Garcia Garcia, Christina Grah, Lothar Müller, Georg Pall, Maria Rosario Garcia Campelo, Santiago Ponce-Aix, Frank Griesinger, J. Riera-Knorrenschild, Michael Schmidt, José Manuel Trigo Perez, Michael Schröder, A. Meyer, Léon Bosquee, Christian Wilfried Scholz, Rudolf M. Huber, Paul Germonpré
المصدر: Annals of Oncology
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Thoracic Tumors, Population, lefitolimod, law.invention, Carboplatin, Maintenance Chemotherapy, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Maintenance therapy, Randomized controlled trial, law, TLR9 agonist, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, education, Survival rate, Etoposide, education.field_of_study, business.industry, Hazard ratio, Cancer, International Agencies, SCLC, Hematology, Original Articles, medicine.disease, Prognosis, Chemotherapy regimen, Small Cell Lung Carcinoma, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Toll-Like Receptor 9, immunotherapy, Cisplatin, business, Immunosuppressive Agents, Leflunomide, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56efb37cb887fb530c467815672b714c
https://pubmed.ncbi.nlm.nih.gov/30137193 -
8
المؤلفون: Paul Germonpré, Tim Van den Wyngaert
المصدر: PLoS ONE
PLoS ONE, Vol 14, Iss 4, p e0215135 (2019)مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Lung Neoplasms, Maximum Tolerated Dose, Science, non-small cell lung cancer (NSCLC), Salvage therapy, Adenocarcinoma of Lung, Antineoplastic Agents, Pemetrexed, Gastroenterology, 03 medical and health sciences, Erlotinib Hydrochloride, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Prospective Studies, Prospective cohort study, Survival rate, Aged, Platinum, Salvage Therapy, Multidisciplinary, business.industry, Middle Aged, medicine.disease, Prognosis, Rash, Survival Rate, Tolerability, 030220 oncology & carcinogenesis, Medicine, Female, Erlotinib, medicine.symptom, business, Engineering sciences. Technology, medicine.drug, Follow-Up Studies
وصف الملف: pdf
-
9
المؤلفون: Leora Horn, Nikoletta L. Kallinteris, David R. Spigel, Ramon Palmero, Joseph Shan, Athanasios Kotsakis, Min Tang, D. Ghizdavescu, David E. Gerber, P. Bidoli, György Losonczy, W-C Su, Hervé Lena, Paul Germonpré, Igor Bondarenko, Martin Reck, Rachel E. Sanborn, Jennifer F. Lai, M. Boyer, Ronald B. Natale, Kwan Park
المساهمون: Gerber, D, Horn, L, Boyer, M, Sanborn, R, Natale, R, Palmero, R, Bidoli, P, Bondarenko, I, Germonpre, P, Ghizdavescu, D, Kotsakis, A, Lena, H, Losonczy, G, Park, K, Su, W, Tang, M, Lai, J, Kallinteris, N, Shan, J, Reck, M, Spigel, D
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Subset Analysis, Oncology, medicine.medical_specialty, Lung Neoplasms, Bavituximab, medicine.medical_treatment, Docetaxel, Adenocarcinoma, Placebo, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Prospective Studies, Lung cancer, Aged, Aged, 80 and over, Salvage Therapy, Chemotherapy, business.industry, Antibodies, Monoclonal, Original Articles, Hematology, Middle Aged, Prognosis, medicine.disease, Chemotherapy regimen, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business, Follow-Up Studies, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e7b58c1ff58194f0d3dbc26722f5ebc
http://hdl.handle.net/10281/260656 -
10
المؤلفون: Djordje Atanackovic, M. Feurer, Jaafar Bennouna, Martin Picard, Eray Goekkurt, Kenneth J. O'Byrne, Maciej Krzakowski, J. Straub, Hervé Lena, Paul Germonpré, Dennis Verhoeven, Wolfgang Schuette, Janusz Milanowski, Christine Hicking, C. F Waller, Aleksandra Szczesna, C. Gridelli, Johan Vansteenkiste, Fabrice Barlesi
المصدر: Annals of Oncology. 26:1734-1740
مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Lung Neoplasms, Cetuximab, Phases of clinical research, non-small cell lung cancer (NSCLC), Cilengitide, Adenocarcinoma, Vinblastine, Deoxycytidine, Disease-Free Survival, chemistry.chemical_compound, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Receptors, Vitronectin, Progression-free survival, Lung cancer, Aged, Proportional Hazards Models, Aged, 80 and over, business.industry, Hazard ratio, Vinorelbine, Hematology, Middle Aged, Integrin alphaVbeta3, Prognosis, medicine.disease, Gemcitabine, Chemotherapy regimen, ErbB Receptors, Treatment Outcome, chemistry, Carcinoma, Squamous Cell, Female, Cisplatin, business, Snake Venoms, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34759ab79cb49f71af02421a4c21b994
https://doi.org/10.1093/annonc/mdv219